USD 18.24
(-3.24%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -260 Million USD | -1833.33% |
2022 | 15 Million USD | -91.76% |
2021 | 182 Million USD | 1170.59% |
2020 | -17 Million USD | -105.7% |
2019 | 298 Million USD | -58.03% |
2018 | 710 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -124 Million USD | 17.88% |
2024 Q1 | -167 Million USD | -209.26% |
2024 Q2 | -151 Million USD | 9.58% |
2023 Q3 | -84 Million USD | -162.5% |
2023 FY | -260 Million USD | -1833.33% |
2023 Q4 | -54 Million USD | 35.71% |
2023 Q2 | -32 Million USD | 63.64% |
2023 Q1 | -88 Million USD | -8700.0% |
2022 Q2 | 5 Million USD | -75.0% |
2022 Q1 | 20 Million USD | -60.78% |
2022 FY | 15 Million USD | -91.76% |
2022 Q4 | -1 Million USD | 93.33% |
2022 Q3 | -15 Million USD | -400.0% |
2021 FY | 182 Million USD | 1170.59% |
2021 Q4 | 51 Million USD | -15.0% |
2021 Q3 | 60 Million USD | 36.36% |
2021 Q2 | 44 Million USD | 62.96% |
2021 Q1 | 27 Million USD | 112.92% |
2020 FY | -17 Million USD | -105.7% |
2020 Q3 | 85 Million USD | 60.38% |
2020 Q2 | 53 Million USD | 0.0% |
2020 Q1 | 53 Million USD | 0.0% |
2020 Q4 | -209 Million USD | -345.88% |
2019 FY | 298 Million USD | -58.03% |
2018 FY | 710 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alcon Inc. | 974 Million USD | 126.694% |
AptarGroup, Inc. | 284.48 Million USD | 191.393% |
Baxter International Inc. | 2.65 Billion USD | 109.789% |
Becton, Dickinson and Company | 1.72 Billion USD | 115.064% |
Haemonetics Corporation | 117.55 Million USD | 321.167% |
Envista Holdings Corp | -100.2 Million USD | -159.481% |
ResMed Inc. | 1.02 Billion USD | 125.466% |
Teleflex Incorporated | 356.32 Million USD | 172.966% |
Warby Parker Inc. | -63.19 Million USD | -311.412% |
West Pharmaceutical Services, Inc. | 593.4 Million USD | 143.815% |